Insiders · Profile

FRIEDMAN CATHY

Director at Lyell Immunopharma. Filing since 21 Jun 2021. CIK 0001411874

Company
Date
Role
Action
Shares
Amount
Of holding
21 Jun 2021
Director
Bought
17,648
$300.02K
opened
1 decision on file.